R Eldor

Summary

Affiliation: Rabin Medical Center
Country: Israel

Publications

  1. ncbi New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies
    R Eldor
    Diabetes Research Centre, Hadassah University Hospital, Ein Kerem, Jerusalem 91120, Israel
    Diabet Med 21:1161-73. 2004
  2. ncbi Early use of insulin in type 2 diabetes
    Roy Eldor
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Diabetes Res Clin Pract 68:S30-5. 2005
  3. doi Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects
    R Eldor
    Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel
    Diabetes Obes Metab 12:219-23. 2010
  4. ncbi Lipids and glucose in type 2 diabetes: what about the beta-cell and the mitochondria?: response to Boden and Laakso
    Roy Eldor
    Diabetes Care 28:985-6; author reply 986-7. 2005
  5. ncbi Intensive insulin therapy in the intensive cardiac care unit
    Tal Hasin
    Department of Cardiology, Rambam Health Care Campus, Haifa, Israel
    Acute Card Care 8:181-5. 2006
  6. ncbi New treatments for diabetes
    Itamar Raz
    N Engl J Med 356:2222; author reply 2222-3. 2007

Detail Information

Publications6

  1. ncbi New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies
    R Eldor
    Diabetes Research Centre, Hadassah University Hospital, Ein Kerem, Jerusalem 91120, Israel
    Diabet Med 21:1161-73. 2004
    ..These new techniques are promising but still mostly unproven and traditional approaches cannot be replaced. New and generally more expensive therapies should be seen as adding to traditional approaches...
  2. ncbi Early use of insulin in type 2 diabetes
    Roy Eldor
    Diabetes Research Center, Department of Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel
    Diabetes Res Clin Pract 68:S30-5. 2005
    ..This new approach, its rationale, benefits and misgivings are discussed in this review...
  3. doi Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects
    R Eldor
    Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel
    Diabetes Obes Metab 12:219-23. 2010
    ..The aim was to determine the optimal adjuvants to insulin ratio which can provide for the best pharmacodynamic profile, while maintaining the safety of the product...
  4. ncbi Lipids and glucose in type 2 diabetes: what about the beta-cell and the mitochondria?: response to Boden and Laakso
    Roy Eldor
    Diabetes Care 28:985-6; author reply 986-7. 2005
  5. ncbi Intensive insulin therapy in the intensive cardiac care unit
    Tal Hasin
    Department of Cardiology, Rambam Health Care Campus, Haifa, Israel
    Acute Card Care 8:181-5. 2006
    ..This review aims to explain the rationale for providing intensive control of serum glucose levels in the ICCU, especially using intensive insulin therapy and summarizes the available clinical evidence suggesting its effectiveness...
  6. ncbi New treatments for diabetes
    Itamar Raz
    N Engl J Med 356:2222; author reply 2222-3. 2007